Merck Sees Significant Institutional Investment Amid Bullish Outlook

Blue Edge Capital LLC has acquired a new position in Merck & Co., Inc. (NYSE:MRK), purchasing 11,499 shares during the second quarter valued at approximately $1,478,000.

This is not an isolated event as other institutional investors have also increased their stakes in the company. California State Teachers Retirement System grew its position by 12,537.4% in the same period and now owns a staggering 484,720,247 shares.

Analysts are optimistic about Merck's future growth, with Bank of America increasing its price objective on MRK from $130 to $141 and maintaining a 'buy' rating. Similarly, Guggenheim raised its target from $146 to $170 and assigned a 'buy' rating.